Online Database of Chemicals from Around the World

Category of Chemicals

P38 MAPK inhibitor

P38 MAPK (Mitogen-Activated Protein Kinase) inhibitors are vital tools in the treatment of inflammatory diseases, as well as certain cancers. By blocking the activity of p38 MAPK, these inhibitors reduce the production of pro-inflammatory cytokines and chemokines, thus dampening the inflammatory response. This makes them essential in combating diseases such as rheumatoid arthritis and inflammatory bowel diseases. Researchers also explore their potential in cancer therapy as inflammation plays a role in tumor progression.

Products of P38 MAPK inhibitor
CAS No.Product NameMolecular Formula
1221485-83-1Skepinone-LC24H21F2NO4
152121-47-6SB 203580C21H16FN3OS
209410-46-8VX-745C19H9Cl2F2N3OS
285983-48-4DoramapimodC31H37N5O3
585543-15-36-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamideC22H26FN3O2
586379-66-0PH 797804C22H19BrF2N2O3
745833-23-2VX 702C19H12F4N4O2
862507-23-15-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonateC24H29FN6.2(CH4O3S)



©  chemBlink. All rights reserved.  Content Disclaimer  |  About chemBlink  |  Contact